Addex Therapeutics ADXN Growth Metrics (2018-2026)

NASDAQ ADXN
$3.05 +0.16 (+5.54%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Addex Therapeutics Quarterly Growth Metrics

Periods 31 quarters
Latest Jun 2026

Addex Therapeutics reported asset growth of -59.55% for the quarter ended Jun 2026. These growth metrics cover 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-9.53%7.77%-32.87%-48.98%-35.05%-63.62%-58.31%-16.10%-46.56%-38.67%-53.64%52.32%115.76%114.79%190.83%-30.10%-36.48%-32.00%-44.74%-59.55%
Assets Growth (3y)
-16.85%-35.91%-35.73%-25.64%-32.03%-37.82%-49.38%-13.29%-9.19%-21.75%-17.47%-3.69%-9.86%-3.60%-9.35%-24.48%
Assets Growth (5y)
-33.69%-19.09%-18.57%-15.23%-15.52%-18.89%-26.92%-28.69%
Assets (QoQ)
-17.32%27.62%-22.35%-37.73%5.26%-28.53%-11.01%25.31%-32.95%-17.97%-32.73%311.74%-5.03%-18.34%-8.92%-1.04%-13.70%-12.58%-25.98%-27.55%
Capital Expenditures Growth (1y)Capex Growth (1y)
-1,696.79%-46.49%95.57%-97.12%-1,897.50%1,067.35%-79.34%
Capital Expenditures Growth (3y)Capex Growth (3y)
76.89%-71.93%32.80%79.13%-151.40%-43.56%-58.90%
Capital Expenditures Growth (5y)Capex Growth (5y)
-44.36%
Capital Expenditures (QoQ)Capex (QoQ)
-244.65%408.67%300.67%-321.50%409.48%-245.21%217.27%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-14.44%5.72%-39.77%-53.03%-35.50%-66.37%-62.03%-13.67%-51.39%-39.20%-70.51%-47.13%-23.33%-19.28%77.56%-31.62%-31.15%-44.06%-63.55%-67.04%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-11.24%-38.59%-39.93%-28.41%-35.51%-39.99%-59.29%-40.15%-37.82%-45.15%-41.63%-32.17%-36.45%-35.01%-42.42%-50.79%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
23.39%-32.23%-35.27%-35.28%-33.24%-32.36%-37.21%-46.54%-45.45%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-15.70%35.25%-28.05%-42.74%15.75%-29.48%-18.75%30.17%-34.82%-11.81%-60.59%133.35%-5.48%-7.15%-13.30%-10.14%-4.82%-24.56%-43.51%-18.73%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
24.85%50.25%99.96%-14,441.14%-586.72%-1,343.48%20,379.24%-4,994.46%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
91.91%32.80%-7.90%-0.55%70.55%-110.22%9.51%-4,646.45%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
35.96%-2.10%326.90%-79.78%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
76.84%-4,563.21%-28,473.48%-3.74%72.28%-76.98%-272.00%-193.45%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
0.49%-509.63%-71.29%14.45%-0.74%0.16%51.37%49.33%8.48%77.97%1.45%0.60%81.96%96.17%73.51%83.37%-44.89%-2,781.89%-46.86%-16.83%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-59.41%-70.26%42.07%-419.16%15.98%21.74%2.83%-42.62%6.37%24.47%45.00%79.66%49.74%56.24%37.92%37.59%27.35%42.19%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-24.43%-28.32%49.73%-25.90%31.14%39.77%24.84%-24.52%20.41%39.11%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
60.92%-15.49%-64.25%-15.40%53.98%-14.46%20.00%-20.24%16.87%72.45%-257.94%-21.27%84.91%94.16%-2,376.46%23.85%-31.44%-16.26%-26.20%39.42%
EBITDA Margin Growth (1y)
1.05M-0.02M-0.20M-0.33M-0.05M-0.30M0.23M0.34M0.08M0.30M-0.02M-0.04M-0.06M-2.75M-0.15M-28.54M
EBITDA Margin Growth (3y)
-0.28M-0.46M-0.03M-0.21M0.04M0.00M1.08M-0.01M0.01M-0.03M-0.03M-2.75M-0.13M-30.99M
EBITDA Margin Growth (5y)
-0.08M-0.16M-0.01M-2.66M0.87M-31.31M
EBITDA Margin (QoQ)
-0.01M0.00M-0.19M-0.14M0.27M-0.24M0.34M-0.03M0.01M-0.02M0.01M-0.05M-0.01M-2.71M-31.10M
EBIT Growth (1y)
-15.16%-24.17%-79.21%-49.00%-10.79%-26.66%93.62%61.54%80.34%96.14%-126.91%64.89%15.34%38.18%25.31%10.98%-21.19%-91.67%9.13%7.76%
EBIT Growth (3y)
-127.30%-58.60%-54.56%-4.16%-13.02%55.17%2.82%36.93%60.69%36.23%41.40%43.08%68.84%52.37%50.65%41.35%64.23%-15.48%33.94%
EBIT Growth (5y)
-45.39%10.49%-18.00%-17.38%28.41%49.01%31.33%22.10%23.77%40.92%29.35%30.24%
EBIT Margin Growth (1y)
1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.35M0.08M0.30M-0.03M-0.04M-0.09M-2.91M-0.12M-28.47M
EBIT Margin Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M-0.01M1.12M-0.02M0.00M-0.03M-0.06M-2.91M-0.13M-31.08M
EBIT Margin Growth (5y)
-0.08M-0.16M-0.04M-2.81M0.91M-31.39M
EBIT Margin (QoQ)
-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M-0.03M0.02M-0.02M0.01M-0.04M-0.04M-2.84M-31.19M
EBIT (QoQ)
21.20%-331.79%62.89%-18.01%41.41%-393.66%98.13%-611.91%70.05%3.00%-9.72%-10.15%27.79%29.17%-32.56%-31.28%1.69%-12.03%37.15%-33.26%
EBT Growth (1y)
-8.88%-104.12%-115.99%-45.77%-8.53%237.36%93.66%60.32%81.08%-115.36%99.79%45.86%-119.12%-34.16%-194,442.02%-46.89%-11.83%-68.91%-33.43%6.71%
EBT Growth (3y)
-42.65%-59.60%-54.26%-5.34%55.84%55.21%2.73%39.31%24.48%93.39%32.09%23.37%34.34%36.19%31.92%22.61%-32.91%-76.13%9.47%
EBT Growth (5y)
32.20%9.34%-14.87%-18.73%13.49%18.13%18.12%6.05%11.34%0.48%5.62%15.56%
EBT Margin Growth (1y)
1.16M-0.01M-0.21M-0.35M-0.05M0.12M0.24M0.35M0.08M-0.17M0.01M-0.08M-0.26M-7.83M-0.25M-66.04M
EBT Margin Growth (3y)
-0.29M-0.48M-0.03M0.14M0.04M-0.01M1.19M-0.05M0.03M-0.08M-0.23M-7.88M-0.43M-74.04M
EBT Margin Growth (5y)
-0.04M-0.21M-0.21M-7.85M0.68M-73.93M
EBT Margin (QoQ)
-0.01M0.04M-0.23M-0.15M0.29M0.21M-0.11M-0.04M0.02M-0.04M0.06M-0.13M-0.16M-7.61M-73.40M
EBT (QoQ)
23.81%-22.43%-31.44%-18.90%43.27%254.94%-106.07%-643.74%72.95%-25.81%99.92%-191,198.16%-9.45%22.97%-20.61%-44.44%16.67%-16.35%4.72%-0.99%
EPS (Basic) Growth (1y)
-7.84%-11.15%-68.89%-14.00%15.11%-79.03%68.84%70.04%47.40%-84.61%17.36%391.06%63.76%-180.76%64.92%-111.83%15.44%-52.59%-21.93%9.30%
EPS (Basic) Growth (3y)
-31.75%-50.52%-46.44%7.25%-51.28%30.07%18.65%21.62%-69.39%24.23%44.13%45.51%-26.54%55.13%53.10%45.58%-29.86%29.29%32.16%
EPS (Basic) Growth (5y)
19.65%-59.98%-18.77%-0.11%31.38%-15.03%37.02%28.62%31.80%-15.27%28.56%36.09%
EPS (Basic) (QoQ)
23.81%466.42%-134.34%-18.89%43.27%190.53%-151.03%-14.33%0.42%126.49%-374.00%502.65%-112.40%40.97%-19.02%-35.75%11.34%-6.52%4.89%-0.99%
EPS (Diluted) Growth (1y)
-180.76%64.92%-111.83%15.44%-52.59%-21.93%9.30%
EPS (Diluted) (QoQ)
-374.00%502.65%-112.40%40.97%-19.02%-35.75%11.34%-6.52%4.89%-0.99%
FCF Margin Growth (1y)
0.90M-0.01M-0.17M-0.25M-0.03M-0.04M0.16M0.27M0.00M0.01M-0.05M-0.20M-0.01M-0.13M-0.11M-24.80M
FCF Margin Growth (3y)
-0.24M-0.36M0.21M-0.05M0.00M0.03M0.87M-0.04M-0.06M-0.17M-0.04M-0.16M-0.11M-24.92M
FCF Margin Growth (5y)
-0.13M-0.28M0.21M-0.17M0.76M-24.98M
FCF Margin (QoQ)
0.03M0.03M-0.19M-0.11M0.25M0.01M0.00M0.00M-0.02M0.03M-0.05M-0.15M0.17M-0.10M-24.80M
Free Cash Flow Growth (1y)FCF Growth (1y)
0.95%-561.30%-71.48%14.56%-1.22%1.42%51.42%49.20%8.89%77.54%1.34%0.87%81.87%95.84%73.51%83.37%-44.89%-2,500.79%-46.86%-16.83%
Free Cash Flow Growth (3y)FCF Growth (3y)
-59.61%-70.32%42.01%-366.65%15.95%21.66%2.97%-44.57%6.33%24.51%44.91%79.04%49.74%56.24%37.91%37.60%27.33%42.25%
Free Cash Flow Growth (5y)FCF Growth (5y)
-24.49%-28.34%49.70%1.04%31.11%39.77%24.83%-25.43%20.39%39.12%
Free Cash Flow (QoQ)FCF (QoQ)
61.16%-17.58%-62.13%-15.40%53.99%-14.52%20.11%-20.69%17.48%71.77%-250.91%-21.27%84.91%93.52%-2,134.90%23.85%-31.44%-16.26%-26.20%39.42%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-2,214.60%-1,049.24%38.01%72.07%79.11%63.84%84.96%67.25%59.66%96.71%-5,467.39%-5,692.34%-72.98%-1,560.79%95.98%87.92%98.37%0.15%-470.43%-336.98%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-47.90%-34.23%20.07%-0.98%43.31%2.86%-24.93%48.46%-73.15%-74.33%47.38%41.73%30.45%-31.82%77.50%18.25%-133.67%-212.66%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
7.60%-65.30%-58.30%18.65%10.84%16.43%-45.00%44.00%-17.82%-3.54%-22.83%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-82.21%62.88%29.20%41.68%-36.25%35.73%70.54%-26.96%-67.82%94.75%-49,675.35%-32.09%94.99%49.60%-20.41%-297.02%99.32%-2,980.92%-587.89%-204.13%
Net Cash Flow Growth (1y)NCF Growth (1y)
0.64%343.63%-190.89%17.79%154.08%-159.79%55.72%151.20%-278.50%77.12%13.21%-197.57%75.80%119.82%76.05%108.90%227.59%-1,200.87%-60.60%-181.55%
Net Cash Flow Growth (3y)NCF Growth (3y)
-61.97%-68.50%28.12%-238.16%16.04%35.49%1.38%-37.63%-32.94%25.67%38.41%-69.96%54.85%26.92%-18.01%20.67%30.63%-27.46%
Net Cash Flow Growth (5y)NCF Growth (5y)
-23.43%-27.66%46.35%30.28%34.23%15.35%18.09%-27.16%-16.37%50.47%
Net Cash Flow (QoQ)NCF (QoQ)
62.21%296.43%-207.57%-2.95%124.86%-317.20%20.34%219.04%-186.66%72.16%-202.21%-33.83%78.50%122.80%-465.11%149.74%208.16%-296.70%46.74%74.74%
Net Income Growth (1y)
-8.88%-104.12%-115.99%-45.77%-8.53%21.00%58.73%60.32%30.34%15.03%-35.90%578.65%40.40%57.26%53.68%-115.62%-11.65%-66.99%-33.43%0.74%
Net Income Growth (3y)
-42.65%-59.60%-54.26%39.22%-0.87%16.38%2.73%6.28%-11.07%-6.60%68.32%23.33%34.05%36.19%33.31%22.61%15.36%5.65%9.47%
Net Income Growth (5y)
-3.23%-14.27%-25.86%25.98%37.79%17.91%18.12%7.21%11.34%0.45%5.62%15.56%
Net Income (QoQ)
23.81%-22.43%-31.44%-18.90%43.27%10.88%31.34%-14.32%0.41%-8.70%-9.82%502.65%-112.40%22.06%-19.02%-35.75%11.34%-16.57%4.89%-0.99%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-8.88%13.62%-115.97%-45.77%-8.55%-72.23%58.73%60.32%30.35%-74.69%-35.91%578.65%40.40%-206.63%53.68%-115.62%-11.65%-66.99%-33.43%0.74%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-22.49%-59.60%-54.26%-5.33%-41.74%16.39%2.73%6.28%-56.93%-6.60%68.32%23.33%-27.55%36.19%33.31%22.61%-34.82%5.65%9.47%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
29.04%-49.53%-25.86%25.98%13.47%-15.48%18.12%7.21%11.34%-16.46%5.63%15.56%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
23.81%568.57%-134.34%-18.89%43.27%219.89%-151.03%-14.33%0.42%143.57%-374.00%502.65%-112.40%22.06%-19.02%-35.75%11.34%-16.57%4.89%-0.99%
Net Margin Growth (1y)
1.16M0.02M-0.21M-0.35M-0.05M0.03M0.20M0.35M0.02M-0.01M-0.08M1.16M-0.20M-8.07M-0.25M-66.08M
Net Margin Growth (3y)
-0.29M-0.48M-0.03M-0.16M-425.00-0.01M1.14M0.04M-0.10M1.16M-0.23M-8.05M-0.43M-74.15M
Net Margin Growth (5y)
-0.18M1.03M-0.21M-8.24M0.68M-74.11M
Net Margin (QoQ)
-0.01M0.11M-0.30M-0.15M0.29M0.18M-0.13M0.01M-0.04M0.15M-0.21M1.25M-1.40M-7.71M-73.54M
Operating Income Growth (1y)Op. Inc Growth (1y)
-15.16%-24.17%-79.21%-49.00%-10.79%-26.66%93.62%61.54%80.34%96.14%-126.91%64.89%15.34%38.18%25.31%10.98%-21.19%-91.67%9.13%7.76%
Operating Income Growth (3y)Op. Inc Growth (3y)
-127.30%-58.60%-54.56%-4.16%-13.02%55.17%2.82%36.93%60.69%36.23%41.40%43.08%68.84%52.37%50.65%41.35%64.23%-15.48%33.94%
Operating Income Growth (5y)Op. Inc Growth (5y)
-45.39%10.49%-18.00%-17.38%28.41%49.01%31.33%22.10%23.77%40.92%29.35%30.24%
Operating Income (QoQ)Op. Inc (QoQ)
21.20%-331.79%62.89%-18.01%41.41%-393.66%98.13%-611.91%70.05%3.00%-9.72%-10.15%27.79%29.17%-32.56%-31.28%1.69%-12.03%37.15%-33.26%
Operating Margin Growth (1y)
1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.35M0.08M0.30M-0.03M-0.04M-0.09M-2.91M-0.12M-28.47M
Operating Margin Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M-0.01M1.12M-0.02M0.00M-0.03M-0.06M-2.91M-0.13M-31.08M
Operating Margin Growth (5y)
-0.08M-0.16M-0.04M-2.81M0.91M-31.39M
Operating Margin (QoQ)
-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M-0.03M0.02M-0.02M0.01M-0.04M-0.04M-2.84M-31.19M
Profit After Tax Growth (1y)PAT Growth (1y)
-8.88%-104.12%-115.99%-45.77%-8.53%237.36%93.66%60.32%81.08%-115.36%99.79%45.86%-119.12%-34.16%-194,442.02%-46.89%-11.83%-68.91%-33.43%6.71%
Profit After Tax Growth (3y)PAT Growth (3y)
-42.65%-59.60%-54.26%-5.34%55.84%55.21%2.73%39.31%24.48%93.39%32.09%23.37%34.34%36.19%31.92%22.61%-32.91%-76.13%9.47%
Profit After Tax Growth (5y)PAT Growth (5y)
32.20%9.34%-14.87%-18.73%13.49%18.13%18.12%6.05%11.34%0.48%5.62%15.56%
Profit After Tax (QoQ)PAT (QoQ)
23.81%-22.43%-31.44%-18.90%43.27%254.94%-106.07%-643.74%72.95%-25.81%99.92%-191,198.16%-9.45%22.97%-20.61%-44.44%16.67%-16.35%4.72%-0.99%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-23.70%2.68%-2.26%-11.68%-15.13%-43.54%-39.33%-35.36%-38.77%-39.85%-95.11%-95.33%-28.68%-46.76%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
106.09%16.04%5.45%3.31%-26.53%-29.61%-70.61%-74.87%-72.77%-72.84%-74.48%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
73.79%24.35%-46.48%-49.02%-58.98%-60.60%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-10.17%36.02%-15.53%-14.43%-13.68%-9.51%-9.23%-8.83%-18.23%-11.11%-14.99%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-799.000.00M-0.01M-0.01M-0.02M-0.02M-0.03M-0.01M-0.01M0.02M0.01M0.04M0.04M0.03M0.04M-0.01M-0.01M-0.02M-0.02M-0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.04M-0.03M-0.02M-0.01M-0.02M0.01M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.02M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.01M0.00M0.00M0.00M0.00M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M-743.000.00M-0.01M-0.01M-0.01M-0.01M0.01M0.00M0.02M-0.01M0.03M-925.000.00M0.00M-0.01M-725.000.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M-0.01M-0.02M-0.03M-0.04M-0.05M-0.02M0.00M0.04M0.01M0.04M0.04M0.02M0.06M0.00M-986.000.00M0.00M-0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.06M-0.04M-0.03M0.00M-0.05M0.01M0.01M0.01M0.02M0.03M0.04M0.05M0.06M0.04M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.01M0.01M0.01M0.01M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M0.00M-0.01M-0.01M-0.01M-0.01M0.02M0.01M0.02M-0.04M0.06M0.00M-57.00-320.00-137.00-471.000.00M0.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M-0.01M-0.02M-0.03M-0.04M-0.05M-0.02M-0.01M0.02M0.06M0.06M0.05M-0.01M-0.01M-0.02M-0.03M-0.02M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.07M-0.04M-0.04M-0.03M0.02M0.02M0.02M0.03M0.02M0.04M0.05M0.06M0.03M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.02M0.00M0.01M0.00M0.00M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M0.00M0.00M-0.01M-0.01M-0.01M-0.01M0.02M0.00M0.01M0.00M0.00M0.00M-0.02M0.00M0.00M-0.01M-0.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.35M0.08M0.30M-0.03M-0.04M-0.09M-2.91M-0.12M-28.47M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M-0.01M1.12M-0.02M0.00M-0.03M-0.06M-2.91M-0.13M-31.08M-0.83M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.08M-0.16M-0.04M-2.81M0.91M-31.39M-0.83M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M-0.03M0.02M-0.02M0.01M-0.04M-0.04M-2.84M-31.19M
Revenue Growth (1y)
2,407.84%-20.31%-72.49%-82.51%-42.93%-82.02%110.81%268.56%-12.48%-71.87%-50.61%-81.83%-83.25%-99.00%-437.95%-40.20%-81.97%
Revenue Growth (3y)
-28.53%-28.37%-5.97%-16.36%-16.63%-7.74%132.25%-65.71%-34.08%-51.08%-56.26%-92.04%-76.72%-55.58%-92.04%
Revenue Growth (5y)
-17.59%-24.45%-34.36%-72.28%-24.30%4.64%-85.15%
Revenue (QoQ)
-31.76%360.35%-92.49%-25.89%122.68%45.06%-11.94%29.56%-47.12%-53.38%54.63%-52.35%-51.25%-97.23%-52,614.71%-99.16%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
25.08%16.85%657.53%85.30%124.04%138.92%-70.10%-20.29%-41.13%-38.27%-5.13%-90.43%-91.89%-91.87%-93.73%-55.63%-57.45%-59.27%5.55%-148.47%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
45.85%11.22%35.45%30.31%14.84%15.29%18.16%19.89%29.04%-47.91%-52.54%-50.68%-73.90%-67.65%-72.72%-72.66%-60.26%-26.42%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-2.52%-36.29%-34.71%-35.56%-38.21%-42.10%-43.63%-43.60%-32.31%-15.22%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
12.35%-28.32%424.12%-56.10%35.84%-23.56%-34.41%17.04%0.32%-19.84%0.80%-88.19%-15.02%-19.59%-22.34%-16.40%-18.49%-23.04%101.27%-138.39%

Addex Therapeutics Growth Metrics API

Pull Addex Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADXN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY